Skip to main content

Cardiopulmonary alterations by ultrasound in a patient with uncomplicated mixed malaria infection: a case report from the Amazon Basin



Information on cardiopulmonary complications in clinical malaria is sparse and diagnosis may be difficult in resource-limited areas due to lack of proper diagnostic tools and access to medical care. A case of pericardial effusion and pulmonary alterations assessed by ultrasound in a patient with uncomplicated mixed malaria infection is described.

Case presentation

A previously healthy 23-year-old male from the Amazon Basin was diagnosed with mixed infection of Plasmodium vivax and Plasmodium falciparum by peripheral blood smear. The patient presented with mild malaria symptoms without signs of severe malaria, but reported moderate chest pain and shortness of breath. Laboratory analyses revealed thrombocytopenia and anemia. The electrocardiogram had PR depressions and bedside ultrasound of the cardiopulmonary system showed pericardial effusion (18 mm) accompanied by multiple B-lines in the lungs, identified as vertical artifacts extending from the pleural line. Cardiac biomarkers were normal. The patient was treated according to national guidelines for malaria and suspected pericarditis, respectively. At follow-up on day 5, the pericardial effusion (9mm) and B-lines had markedly decreased. By day 21 the patient was asymptomatic, had completed the treatment, and the electrocardiogram and ultrasound findings had normalized.


This case report highlight the usefulness of bedside ultrasound to identify cardiopulmonary involvement in patients with uncomplicated malaria and relevant symptoms.


Information on cardiopulmonary complications in malaria is limited and only sporadically reported in clinical studies [1, 2]. Adequate and timely diagnosis of these complications may be difficult in low- and middle-income countries where access to healthcare facilities and diagnostic imaging tools are limited. Bedside ultrasound examination, including echocardiography and lung ultrasound (LUS), is a non-invasive tool that can detect cardiopulmonary alterations [1]. Both modalities may be conducted outside of clinical wards and has previously been demonstrated useful in resource limited settings [2,3,4]. Pericardial effusion by echocardiography has been described in several reports of Plasmodium vivax and Plasmodium falciparum [5,6,7,8,9,10,11], but is not routinely assessed in patients with malaria. B-lines assessed by LUS are vertical artifacts starting from pleura and are caused by an increase in interstitial density. They are associated with cardiac and pulmonary conditions [112] and one prior study has reported on B-lines in patients with malaria [2].

A case of pericardial effusion and B-lines in a patient with uncomplicated mixed malaria infection, who presented with chest pain and shortness of breath is reported. The aim of this case report is to describe the potential usefulness of ultrasound for identifying cardiopulmonary complications in relevant patients suffering from uncomplicated malaria.

Case presentation

A 23-year-old Brazilian male with no prior history of cardiopulmonary disease was diagnosed with P. vivax and P. falciparum by peripheral blood smear (16560 parasites/µL) in the emergency care unit (UPA, Cruzeiro do Sul, Acre, Brazil). 48 days earlier he had completed treatment for mono-infection of P. vivax (peripheral blood smear, 300 parasites/µL) with primaquine 30 mg (7 days) and chloroquine 600 mg (day 1) + 450 mg (day 2 and 3). The patient now presented with headache and chills and reported onset of stabbing chest pain and shortness of breath 3 days prior to examination.

The patient was circulatory stable (blood pressure 110/62 mmHg; heart rate 109 beats/min), auscultation of heart and lungs was normal. Axillary temperature was < 37.5 °C. Laboratory results showed inflammation (C-reactive protein 96 mg/L), thrombocytopenia (platelets 99/mm3) and moderate anemia (hemoglobin 9.2 g/dL). Liver function was slightly affected (aspartate aminotransferase 47 U/L). Cardiac biomarkers were all within normal range (pro-brain natriuretic peptide 24 pg/mL; troponins < 0.001 ng/mL). The electrocardiogram (ECG) showed PR-depressions in lead I, II, aVF and V1–V6. Ultrasound revealed pericardial effusion (18 mm) and 24 B-lines by LUS (Table 1; Fig. 1), which was assessed as the sum of B-lines in eight thoracic zones. All other echocardiographic measurements were within normal range, including left ventricular ejection fraction (> 50 %) and right ventricular function and no pleural effusions were found. Test for coronavirus by polymerase chain reaction was negative. The patient started treatment the same day with (i) primaquine 30 mg (14 days) (ii) artemether 80 mg + lumefantrine 480 mg × 2 (3 days) and (iii) colchicine 0.5 mg × 2 + ibuprofen 600 mg (7 days).

Table 1 Overview of ultrasound findings and biochemistry at day 0, 5 and 21
Fig. 1

Images of cardiopulmonary complications in malaria by day 0, 5 and 21. Upper row shows B-lines by lung ultrasound (white artefacts extending from the pleura) and the lower row displays pericardial effusion measured next to the right ventricle

Follow-up day 5: Chest pain and shortness of breath improved after initiation of treatment and the patient reported to be compliant with the medication. The ECG showed sinus rhythm without PR-depressions. The pericardial effusion was reduced to 9 mm and 6 B-lines were observed. Blood sample analyses showed a decrease in C-reactive protein (32 mg/L) and peripheral blood smears were negative for Plasmodium species.

Follow-up day 21: The patient reported to be free from all symptoms and peripheral blood smears were negative. Ultrasound displayed no significant pericardial effusion (< 5 mm) and 0 B-lines.


This case report has two principal findings: (i) Malaria patients who present with cardiac complaints may suffer from unrecognized cardiopulmonary complications, and (ii) bedside ultrasound examination may be a useful method to identify such cardiac disturbances. Recently, a meta-analysis by Holm et al. found that cardiovascular complications in malaria are only sporadically reported and may be underestimated [13]. Specifically, ECG and left ventricular dysfunction were among the most prevalent complications associated with malaria. As well, a clinical study from the Amazon Basin found that non-severe P. vivax infection (n = 26 outpatients) was associated with subclinical right ventricular function (i.e., lower fractional area change) in the symptomatic phase of the malaria infection [14]. In this case, left and right ventricular function were normal at baseline and at follow-up (Table 1). By contrast, PR-depressions were seen in the ECG and pericardial effusion in the absence of myocardial affection, thus implying pericarditis [1516]. Colomba et al. reported similar findings in a malaria case and suggested that local inflammation might increase vascular permeability, leading to accumulation of pericardial fluid [6]. Other suggested mechanisms include cytoadhesion of infected erythrocytes to the coronary endothelium [17] and release of pro-inflammatory cytokines due to vascular endothelial dysfunction in the myocardial vessels [1819]. Despite a plethora of proposed mechanisms, no consensus exists as to how malaria affects the heart.

Inflammatory changes also occur in the lungs during malaria [2021]. Although pulmonary edema represents a criteria for severe malaria infection, and is associated with high mortality, lung complications are also seen in uncomplicated cases [2022]. Lung impairment may appear in mono-infections of P. vivax and P. falciparum, however, occurs more frequently in mixed malaria infections [23]. In the present case it is possible that the patient had a relapse of P. vivax followed by a superinfection of P. falciparum, increasing the risk of pulmonary involvement. Consequently, multiple B-lines by LUS were observed, indicating presence of extravascular lung water [23]. One prior clinical study also reported B-lines in malaria patients, however, the sample size was small (n = 31), the population consisted of adults and children, and no relationship was found with degree of malaria severity, which was defined by a combination of clinical parameters and high parasite density (parasite count > 100,000/mm) [2].

During the follow-up examinations, the patient reported a relief in cardiac complaints which was accompanied by a concomitant decrease in pericardial effusion and B-lines. This indicates a correlation between cardiac symptoms and cardiopulmonary findings by ultrasound. Malaria patients presenting with key cardiac symptoms (i.e., chest pain, shortness of breath) could potentially constitute a high-risk group, who may benefit from ultrasound of the cardiopulmonary system as part of the early clinical assessment. Furthermore, B-lines demonstrated a dynamic nature throughout the follow-up examinations and could, on a hypothesis-generating basis, be used for monitoring of pulmonary involvement in malaria; similar to what has been reported in other patient groups such as heart failure and sepsis [21223].

Bedside ultrasound examination represents an easily applicable diagnostic tool, which may provide accurate information for diagnosis of cardiopulmonary involvement in clinical malaria cases. LUS may be particularly useful as it can be applied by non-medical personnel with high sensitivity and specificity [24], and even is applicable in resource-limited settings [4]. Timely use of ultrasound in relevant patients with malaria may possibly facilitate risk stratification, therapeutic decisions and effective management and should be explored in future prospective cohort studies of malaria patients.


This case report highlights the usefulness of bedside ultrasound to identify cardiopulmonary involvement in patients with uncomplicated malaria and relevant symptoms.

Availability of data and materials

The datasets used and analyzed during the current study are available from the corresponding author in reasonable request.


  1. 1.

    Price S, Platz E, Cullen L, Tavazzi G, Christ M, Cowie MR, et al. Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failure. Nat Rev Cardiol. 2017;14:427–40.

    Article  Google Scholar 

  2. 2.

    Leopold SJ, Ghose A, Plewes KA, Mazumder S, Pisani L, Kingston HWF, et al. Point-of-care lung ultrasound for the detection of pulmonary manifestations of malaria and sepsis: an observational study. PLoS One. 2018;13:e0204832.

    CAS  Article  Google Scholar 

  3. 3.

    Bhavnani SP, Sola S, Adams D, Venkateshvaran A, Dash PK, Sengupta PP, et al. A randomized trial of pocket-echocardiography integrated mobile health device assessments in modern structural heart disease clinics. JACC Cardiovasc Imaging. 2018;11:546–57.

    Article  Google Scholar 

  4. 4.

    Gustafsson M, Alehagen U, Johansson P. Imaging congestion with a pocket ultrasound device: prognostic implications in patients with chronic heart failure. J Card Fail. 2015;21:548–54.

    Article  Google Scholar 

  5. 5.

    Ruhela M, Khandelwal G, Gupta S, Bansal A. Falciparum malaria mimicking acute myocardial infarction. J Fam Med Prim Care. 2019;8:308.

    Article  Google Scholar 

  6. 6.

    Colomba C, Trizzino M, Gioè C, Coelho F, Lopo I, Pinheiro P, et al. Malaria and the heart: Two rare case reports of Plasmodium falciparum-associated pericarditis. J Vector Borne Dis. 2017;54:372–4.

    Article  Google Scholar 

  7. 7.

    Sonambekar AA, Gupta N, Agarwal MP, Rajpal S, Aggarwal A. Plasmodium vivax-associated myopericarditis. EJCRIM. 2014;1.

  8. 8.

    Gupta N, Sahoo S. Plasmodium vivax induced myocarditis: a rare case report. Indian J Med Microbiol. 2013;31:180–1.

    CAS  Article  Google Scholar 

  9. 9.

    Maheshwari M, Saini T. Plasmodium vivax malaria complicated by pericardial effusion. Indian Med Gaz. 2012;145:199–201.

    Google Scholar 

  10. 10.

    Franzen D, Curtius JM, Heitz W, Höpp HW, Diehl V, Hilger HH. Cardiac involvement during and after malaria. Clin Investig. 1992;70:670–3.

    CAS  Article  Google Scholar 

  11. 11.

    Ray HN, Doshi D, Rajan A, Singh AK, Singh SB, Das MK. Cardiovascular involvement in severe malaria: a prospective study in Ranchi, Jharkhand. J Vector Borne Dis. 2017;54:177–82.

    Article  Google Scholar 

  12. 12.

    Platz E, Jhund PS, Girerd N, Pivetta E, McMurray JJV, Peacock WF, et al. Expert consensus document: reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure. Eur J Heart Fail. 2019;21:844–51.

    Article  Google Scholar 

  13. 13.

    Holm AE, Gomes LC, Marinho CRF, Silvestre OM, Vestergaard LS, Biering-Sørensen T, et al. Prevalence of cardiovascular complications in malaria: a systematic review and meta-analysis. Am J Trop Med Hyg. 2021;104:1643–50.

    Article  Google Scholar 

  14. 14.

    Alencar-Filho AC, Ferreira JMBB, Salinas JL, Fabbri C, Monteiro WM, Siqueira AM, et al. Cardiovascular changes in patients with non-severe Plasmodium vivax malaria. IJC Hear Vasc. 2016;11:12–6.

    Article  Google Scholar 

  15. 15.

    Spodick DH. Electrocardiographic Sequences. Circulation. 1973;48:575–80.

    CAS  Article  Google Scholar 

  16. 16.

    Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36:2921–64.

    Article  Google Scholar 

  17. 17.

    Filho AC, de A, Guimarães, de Lacerda MV, Okoshi K, Okoshi MP. Malaria and vascular endothelium. Arq Bras Cardiol. 2014;103:165–9.

    Google Scholar 

  18. 18.

    Moxon CA, Chisala NV, Wassmer SC, Taylor TE, Seydel KB, Molyneux ME, et al. Persistent endothelial activation and inflammation after Plasmodium falciparum infection in Malawian children. J Infect Dis. 2014;209:610–5.

    CAS  Article  Google Scholar 

  19. 19.

    Rose NR. Critical cytokine pathways to cardiac inflammation. J Interf Cytokine Res. 2011;31:705–10.

    CAS  Article  Google Scholar 

  20. 20.

    Val F, Machado K, Barbosa L, Salinas JL, Siqueira AM, Alecrim MGC, et al. Respiratory complications of Plasmodium vivax malaria: systematic review and meta-analysis. Am J Trop Med Hyg. 2017;97:733–43.

    Article  Google Scholar 

  21. 21.

    Taylor WRJ, Hanson J, Turner GDH, White NJ, Dondorp AM. Respiratory manifestations of malaria. Chest. 2012;142:492–505.

    Article  Google Scholar 

  22. 22.

    WHO. Guidelines for the treatment of malaria. 3rd ed. Geneva: World-Health-Organization; 2015.

    Google Scholar 

  23. 23.

    Kotepui M, Kotepui KU, De Jesus Milanez G, Masangkay FR. Plasmodium spp. mixed infection leading to severe malaria: a systematic review and meta-analysis. Sci Rep. 2020;10:11068.

    CAS  Article  Google Scholar 

  24. 24.

    Swamy V, Brainin P, Biering-Sørensen T, Platz E. Ability of non-physicians to perform and interpret lung ultrasound: a systematic review. Eur J Cardiovasc Nurs. 2019;18:474–83.

    Article  Google Scholar 

Download references




AW was supported by the Danish Heart Association (20-R139-A9644-22165). PB was supported by a research Grant from The Independent Research Fund Denmark (0129-00003B), A.P. Møllers Lægefond and Dansk Medicinsk Selskab København. LCG: CNPq (142306/2020-7). CRFM: FAPESP (2020/06747-4) and CNPq (302917/2019-5).

Author information




AW, KL, AH and PB were responsible for writing the article. KL, LG, LM, IV, AH, AW and PB collected and analyzed the data. PB was responsible for the quality of the collection and analysis of the data. LV, CM, RS TBS and OS critically revised of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Alma Wegener.

Ethics declarations

Ethics approval and consent to participate

The study was approved by a local scientific ethical committee and by the Brazilian Institutional Review Board (CAAE 26552619.6.0000.510/4.056.296). The study complied with the 2nd Declaration of Helsinki, and the patient gave written informed consent.

Consent for publication

Written informed consent was obtained from the patient for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wegener, A., Lima, K.O., Holm, A.E. et al. Cardiopulmonary alterations by ultrasound in a patient with uncomplicated mixed malaria infection: a case report from the Amazon Basin. Malar J 20, 330 (2021).

Download citation


  • Malaria
  • Heart disease
  • Pericardial effusion
  • Pericarditis
  • Echocardiography
  • Lung ultrasound